1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25 | On 3-23-23 at 11:00am, Licensing Program Analyst (LPA) Michael Bilger conducted a case management visit regarding infection control practices, reporting requirements, and medication practices. LPA met with Administrator Orchid Damrichob and explained the purpose of the visit. LPA conducted facility observation on 1-19-23, reviewed facility file documentation for resident1 (R1), and conducted interview with Administrator on 1-19-23. Based on observation, record review and interviews, the following was determined: (1) On 1-19-23, it was determined that R1 contracted scabies and was not cleared of contagious disease. During facility tour, LPA did not observe isolation carts in place to promote appropriate infection control practices for residents, staff, and visitors. Additionally, based on interview, it was determined that an isolation cart was not present after facility staff learned of R1’s diagnosis of scabies. (2) Upon learning of R1’s scabies diagnosis after R1’s hospitalization on 1-4-23 for an unrelated condition, it was further determined through interview and record review that facility did not report incident to licensing department per regulatory requirements. Repot was eventually received on 1-26-23. (3) Based on review of care notes for R1 and interview conducted, it was determined that R1 experienced behavioral episodes between the dates of 11/6/2022 and 1/4/2023 which were not identified on R1’s needs and service plan upon his admission on 6/10/2022. Further interview and record review revealed needs and service plans were not updated to reflect new onset of behaviors and accompanying necessary interventions. {Cont. on 809C} |